DAFNA Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,100
| Closed | -$51K | – | 84 |
|
|
2020
Q2 | $51K | Sell |
6,100
-93,900
| -94% | -$785K | 0.01% | 87 |
|
|
2020
Q1 | $767K | Hold |
100,000
| – | – | 0.32% | 57 |
|
|
2019
Q4 | $831K | Hold |
100,000
| – | – | 0.29% | 61 |
|
|
2019
Q3 | $738K | Buy |
+100,000
| New | +$738K | 0.28% | 64 |
|
|
2017
Q4 | – | Sell |
-5,900
| Closed | -$107K | – | 74 |
|
|
2017
Q3 | $107K | Buy |
+5,900
| New | +$107K | 0.07% | 71 |
|